ADJUNCTIVE THERAPY OF COMMUNITY-ACKUIRED PNEUMONIA: NECESSITY AND SUFFICIENCY

ADJUNCTIVE THERAPY OF COMMUNITY-ACKUIRED PNEUMONIA: NECESSITY AND SUFFICIENCY

Objective: analysis of pathogenetic and symptomatic therapy of community-acquired pneumonia in the prehospital and at the stage of hospital treatment of disease in hospitals of city Khujand of the Republic of Tajikistan.Materials and methods: A retrospective analysis of 393 case histories of pa...

Full description

Saved in:

Bibliographic Details
Main Authors:	L. V. Savchenkova, M. N. Saidova, N. S. Sanginova
Format:	Article
Language:	Russian
Published:	Journal Infectology 2016-12-01
Series:	Журнал инфектологии
Subjects:	community-acquired pneumonia pharmacotherapy polypharmacy
Online Access:	https://journal.niidi.ru/jofin/article/view/528
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

СLINICAL AND IMMUNOLOGICAL EFFICIENCY OF IMUNOFAN AND POLYOXIDONIUM IN COMBINED THERAPY OF COMMUNITY-ACQUIRED PNEUMONIA
by: L. R. Mukhamadieva, et al.
Published: (2014-07-01)

Novelties in the treatment of community-acquired and hospital-acquired pneumonia
by: Matteo Bassetti, et al.
Published: (2025-04-01)

Antibiotic Therapy of Severe Community-Acquired Pneumonia
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Nonlinear main components of the cytokine profile in children with community-acquired pneumonia
by: N. V. Iziurova, et al.
Published: (2024-01-01)

Pharmacoeconomic analysis of first-choice antimicrobial drugs prescribed for outpatient treatment of non-severe community-acquired pneumonia
by: V. G. Deriushkin, et al.
Published: (2021-02-01)

Features of laboratory indicators of severe community-acquired pneumonia.
by: T. A. Pertzeva, et al.
Published: (2017-06-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

The anti-inflammatory and antioxidant effects of astaxanthin as an adjunctive therapy in community-acquired pneumonia: a randomized controlled trial
by: Fatma Makram Youssef, et al.
Published: (2025-08-01)

The Role of Ultrasound in Diagnosing Community-Acquired Pneumonia
by: D. O. Starostin, et al.
Published: (2023-02-01)

Cytokine profile in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2022-11-01)

Community-acquired pneumonia in HIV patients
by: I. B. Viktorova, et al.
Published: (2021-05-01)

Antibiotic Therapy of Mild Community-Acquired Pneumonia in Inpatients
by: O. V. Molchanova, et al.
Published: (2020-05-01)

Clinical and Etiological Features of Community-acquired Pneumonia in Children in Vladivostok
by: L. G. Erokhina, et al.
Published: (2015-12-01)

MULTILOCI SEQUESTERANT STRAINS OF STREPTOCOCCUS PNEUMONIAE ISOLATED FROM ELDERLY PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
by: A. V. Martynova, et al.
Published: (2014-06-01)

The Practice of Antibiotic Therapy of Severe Community-Acquired Pneumonia in Adults in Russian Multidisciplinary Hospitals
by: S. A. Rachina, et al.
Published: (2022-04-01)

Mycoplasma pneumoniae infection in hospitalized adult patients with community-acquired pneumonia in China
by: Zongxiao Shangguan, et al.
Published: (2014-10-01)

Immunological aspects of cytomegalovirus infection in community-acquired pneumonia among young adults.
by: K. D. Chichirelo-Konstantynovych, et al.
Published: (2018-04-01)

Epidemiological parallels of community-acquired pneumonia, influenza and ARVI in Moscow
by: T. S. Saltykova, et al.
Published: (2020-04-01)

Comparison between community-acquired pneumonia and post-obstructive pneumonia associated with endobronchial tumors
by: Wenwen Yu, et al.
Published: (2024-11-01)

Optimizing antibiotic therapy of group IV community-acquired pneumonia patients
by: Dziublyk Ya.O.
Published: (2014-06-01)

Role of Inflammatory Markers as a Risk Factor for Community-Acquired Pneumonia Management
by: Ruta Nutautiene, et al.
Published: (2025-06-01)

Characterization of the oxidative metabolism of erythrocytes in patients with community-acquired pneumonia
by: L. A. Demidchik, et al.
Published: (2016-05-01)

Community versus academic hospital community-acquired pneumonia patients: a nested cohort study
by: Jennifer L.Y. Tsang, et al.
Published: (2024-11-01)

An analysis of HRCT imaging characteristics and sputum culture results in hospitalized patients with community-acquired pneumonia - an institutional observational study
by: Keesari Sai Sandeep Reddy, et al.
Published: (2024-06-01)

Comparative characteristics of pneumonia caused by <i>Mycoplasma pneumoniae</i> in children
by: S. L. Bevza, et al.
Published: (2023-10-01)

Modern approaches at the management of children with community-acquired pneumonia
by: Aleksander A. Baranov, et al.
Published: (2023-03-01)

Prognostic value of peripheral blood lymphocytes in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2025-06-01)

Fatal Community-Acquired Pneumonia: 18 Years in a Medical Center
by: Ling-Jen Wang, et al.
Published: (2013-02-01)

Comparative analysis of Chlamydia pneumoniae pneumonia (CPP) and Mycoplasma pneumoniae pneumonia in children and risk factors of severe CPP
by: Yu HUANG, et al.
Published: (2025-08-01)

Discussion questions about community-acquired pneumonia in children
by: N. A. Geppe, et al.
Published: (2014-03-01)

Alterations in the prevalence and serotypes of Streptococcus pneumoniae in elderly patients with community-acquired pneumonia: a meta-analysis and systematic review
by: Xinyue Luo, et al.
Published: (2025-02-01)

Risk factors and prediction model construction for poor outcome in asthma combined with severe community-acquired pneumonia in children
by: WANG Fanrong, et al.
Published: (2024-05-01)

The Effectiveness of Immunomodulatory Therapy of Community-acquired Pneumonia in Frequently ill Children
by: T. G. Malanicheva, et al.
Published: (2018-12-01)

Features of the clinical presentation and course of community-acquired pneumonia against the background of type 2 diabetes mellitus
by: A. A. Zaytseva, et al.
Published: (2022-07-01)

The improved prediction value of neutrophil to lymphocyte ratio to pneumonia severity scores for mortality in the older people with community-acquired pneumonia
by: Lixue Huang, et al.
Published: (2025-07-01)

Problems of assessing the severity of the state of elderly patients with community-acquired pneumonia caused by Klebsiella pneumoniae
by: V. I. Sakharov, et al.
Published: (2020-12-01)

Community-acquired pneumonia: risk factors, prognosis, microbial etiology, treatment, and prophylaxis
by: Catia Cilloniz, et al.
Published: (2025-04-01)

Diagnostic value of bronchoalveolar lavage in children with nonresponding community-acquired pneumonia
by: Chih-Min Tsai, et al.
Published: (2017-10-01)

Use of medications in children hospitalized with community-acquired pneumonia
by: D. D. Siukaeva, et al.
Published: (2018-11-01)

Serum cytokine levels in children with community-acquired pneumonia caused by different respiratory pathogens
by: Yuanhui Duan, et al.
Published: (2025-05-01)